CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 98 filers reported holding CULLINAN ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131 | -15.5% | 14,402 | 0.0% | 0.00% | – |
| Q2 2023 | $155 | +7.6% | 14,402 | +2.6% | 0.00% | – |
| Q1 2023 | $144 | -2.7% | 14,037 | -0.1% | 0.00% | – |
| Q4 2022 | $148 | -99.9% | 14,052 | +3.2% | 0.00% | – |
| Q3 2022 | $175,000 | +15.9% | 13,617 | +15.9% | 0.00% | – |
| Q2 2022 | $151,000 | +30.2% | 11,746 | +5.6% | 0.00% | – |
| Q1 2022 | $116,000 | -29.3% | 11,127 | +4.7% | 0.00% | – |
| Q4 2021 | $164,000 | -99.5% | 10,627 | -98.5% | 0.00% | -100.0% |
| Q1 2021 | $30,152,000 | – | 723,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |